T1	Participants 87 158	in autism: a randomized, double-blind, placebo-controlled clinical tria
T2	Participants 489 688	participants were referred outpatients between 4 and 12 years of age with the diagnosis of ADs and a score of more than 12 on Aberrant Behavior Checklist-Community (ABC-C) Irritability subscale score
T3	Participants 1127 1169	Forty patients completed the 10-week trial
